Pat PurcellMeeting Engagement
Suma Ramadas, PhDMedical Affairs
Stacey GandlerBrand Nourishment
Paul TheisenPatient Acquisition
Bud BilanichSuccess Coach
Matt TurnerPatient Affordability
Joey CohenMedication Adherence
Brenda SnowAuthentic Patient Voice
David LinetskyPoint-of-Care Marketing
Liz KaneImpactful Strategy
Matthew DurhamOmnidynamic Marketing
Amy GilesIncreasing Engagement
Frank BurrellScientific Storytelling
Daniel SontupeMarket Access
Initiated a Phase 1 trial of SRF231, a fully human antibody targeting CD47 Completed ...
38% Objective Response Rate (ORR) demonstrated in 47 Metastatic Melanoma patients who were unsuccessfully ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email